In anaplastic thyroid cancer, NSUN2 regulates SRSF6 splicing to enhance UAP1 and ABC transporter function, inducing multidrug resistance reversible by NSUN2 targeting [282]. Here, SRSF6 is linked to thyroid gland undifferentiated (anaplastic) carcinoma.